We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bacterial Toxin Sets the Course for Infection

By LabMedica International staff writers
Posted on 21 Nov 2013
Various toxins and effector proteins of bacterial pathogens have been found to manipulate eukaryotic cell machineries to promote persistence and proliferation within their hosts.

Some isolates of Yersinia pseudotuberculosis produce the cytotoxic necrotizing factor (CNFγ), but the functional consequences of this toxin for host-pathogen interactions during the infection are unknown.

Scientists at Helmholtz Center for Infection Research (Brunswick, Germany) cultured Yersinia strains in Luria-Bertani (LB) broth at 25 °C or 37 °C. More...
All DNA manipulations, polymerase chain reactions, restriction digestions, ligations, and transformations were performed using standard techniques. The β-galactosidase activity was determined for three independent cultures of bacteria.

Activation of Ras homolog gene family, member A (RhoA) was tested using the Rho activation assay kit (Millipore; Billerica, MA, USA) and activation of ras-related C3 botulinum toxin substrate 1 (Rac1) and cell division control protein 42 homolog (Cdc42) was determined with the Rho/Rac/Cdc42 Activation Assay Combo Kit (Cell Biolabs; San Diego, CA, USA).

In order to elucidate its function, the scientists genetically modified a bacterial strain that usually forms CNFγ in such a way that it lost the ability to produce this factor. They identified the molecular target that CNFγ manipulates, generating the dramatic consequences that involve the so-called small Rho guanosine triphosphate enzymes (GTPases). These enzymes initiate a whole cascade of events, for example alteration of the cytoskeleton. This leads to pores in the host cell surface, through which bacterial syringes can more efficiently transport active agents into the cell. The observed cell mortality of the immune cells is introduced through Rho GTPases as well.

Petra Dersch, PhD, a professor and senior author of the study explained, “We have discovered a very clever strategy of Yersinia pseudotuberculosis. With the aid of CNFγ, the bacterium manipulates the host cell in such a manner that the injection apparatus can work more effectively. It sets the course for an efficient infection and triggers onset of the disease.” The authors concluded that CNFγ is important for pathogenicity by showing that this toxin modulates inflammatory responses, protects the bacteria from attacks of innate immune effectors and enhances the severity of a Yersinia infection. The study was published on November 7, 2013, in the journal Public Library of Science Pathogens.

Related Links:

Helmholtz Centre for Infection Research
Millipore 
Cell Biolabs 



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.